Minimal Residual Disease Quantification by Next-generation Sequencing in Pediatric B-ALL Children Patients Treated With Blinatumomab Consolidation

Clinical trial NCT05837689 · UNKNOWN

Trial details

NCT number: NCT05837689
Sponsor: Xiaojun Xu
Status: UNKNOWN
Study type: OBSERVATIONAL

Acute Lymphoblastic Leukemia, Pediatric

Start date: 2023-04-01
Primary completion: 2023-04-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.